Early Closure of a Temporary Ileostomy in Patients With Rectal Cancer:A Multicenter Randomized Controlled Trial by Danielsen, Anne K et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Early Closure of a Temporary Ileostomy in Patients With Rectal Cancer
Danielsen, Anne K; Park, Jennifer; Jansen, Jens E; Bock, David; Skullman, Stefan; Wedin,
Anette; Marinez, Adiela Correa; Haglind, Eva; Angenete, Eva; Rosenberg, Jacob
Published in:
Annals of Surgery
DOI:
10.1097/SLA.0000000000001829
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY-NC-ND
Citation for published version (APA):
Danielsen, A. K., Park, J., Jansen, J. E., Bock, D., Skullman, S., Wedin, A., ... Rosenberg, J. (2017). Early
Closure of a Temporary Ileostomy in Patients With Rectal Cancer: A Multicenter Randomized Controlled Trial.
Annals of Surgery, 265(2), 284-290. https://doi.org/10.1097/SLA.0000000000001829
Download date: 03. Feb. 2020
RANDOMIZED CONTROLLED TRIALEarly Closure of a Temporary Ileostomy in Patients
With Rectal Cancermized Controlled TrialA Multicenter RandoAnne K. Danielsen, PhD, MA(Ed), MA(ClN), RN, Jennifer Park, MD,y Jens E. Jansen, MD,z
David Bock, PhD,y Stefan Skullman, MD, PhD,§ Anette Wedin, RN,y Adiela Correa Marinez, MD,y
Eva Haglind, MD, PhD,y Eva Angenete, MD, PhD,y and Jacob Rosenberg, MD, DScObjective: The objective was to study morbidity and mortality associated
with early closure (8–13 days) of a temporary stoma compared with standard
procedure (closure after > 12 weeks) after rectal resection for cancer.
Background: A temporary ileostomy may reduce the risk of pelvic sepsis
after anastomotic dehiscence. However, the temporary ileostomy is afflicted
with complications and requires a second surgical procedure (closure) with its
own complications. Early closure of the temporary ileostomy could reduce
complications for rectal cancer patients.
Methods: Early closure (8–13 days after stoma creation) of a temporary
ileostomy was compared with late closure (>12 weeks) in a multicenter
randomized controlled trial, EASY (www.clinicaltrials.gov, NCT01287637)
including patients undergoing rectal resection for cancer. Patients with a
temporary ileostomy without signs of postoperative complications were
randomized to closure at 8 to 13 days or late closure (>12 weeks after index
surgery). Clinical data were collected up to 12 months. Complications were
registered according to the Clavien-Dindo Classification of Surgical Com-
plications, and Comprehensive Complication Index was calculated.
Results: The trial included 127 patients in eight Danish and Swedish surgical
departments, and 112 patients were available for analysis. The mean number
of complications after index surgery up to 12 months follow up was
significantly lower in the intervention group (1.2) compared with the control
group (2.9), P < 0.0001.
Conclusions: It is safe to close a temporary ileostomy 8 to 13 days after rectal
resection and anastomosis for rectal cancer in selected patients without Copyright © 2016 Wolters Kluw
clinical or radiological signs of anastomotic leakage.
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P atients with low rectal cancer often receive a temporary ileos-tomy at the time of resection of the rectum to reduce the risk of
symptomatic anastomotic dehiscence.1 The temporary ileostomy
was introduced to decrease the clinical consequences of an anasto-
motic leak but it has not been shown to reduce the risk of anastomotic
leakage as such.2 However, studies have shown complication rates up
to 43% related to the temporary ileostomy,3 including readmissions,
dehydration, and chronic renal failure.4 Most patients with a tempor-
ary ileostomy will keep their stoma at least 3 months, and it is not
unusual that the stoma is left in place much longer, and for a few
patients it becomes permanent.5
Closure of the temporary ileostomy is associated with a low
mortality,6 but the morbidity may be more than 20%.3 Timing of
stoma closure has previously been investigated in a few prospective
studies that mainly focused on morbidity and mortality related to
early closure of the stoma.7–9 These studies did not demonstrate any
significant effect on morbidity or mortality related to early closure. In
other studies investigating the possibility of an earlier closure, the
results have been promising.10,11
The aim of this trial was to explore if morbidity and mortality
was reduced within 12 months after rectal resection in patients
treated for low rectal cancer, and if the stoma was closed early
(8–13 days after stoma creation) compared with late closure of the
temporary ileostomy (a minimum of 12 weeks after stoma creation).
The primary endpoint was the mean number of complications after
index-operation and up to 12 months. Two secondary endpoints were
(i) the proportion of patients with at least one complication with
Clavien-Dindo Classification of Surgical Complications (Clavien-
Dindo classification)12,13 severity grade IIIa, IIIb, IVa, IVb, or Vafter
index surgery and up to 12 months and (ii) the mean number of
stoma-related complications after index surgery and up to 12 months.
Supporting endpoints were the Comprehensive Complication Index
14(CCI) after index surgery and up to 12 months and creatinine levels.METHODS
Design
The trial was designed as a randomized controlled multicenter
trial comparing early with late closure of temporary ileostomy in
eight Danish and Swedish surgical departments. Screening for and
inclusion of participants was made after the index surgery (total
mesorectal excision (TME) for rectal cancer) with creation of aer Health, Inc. All rights reserved.
temporary ileostomy. Follow-up of patients was at the time of
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designed and performed within the framework of the Scandinavian
Surgical Outcomes Research Group (http://www.ssorg.net). The
protocol for the EASY-trial (Early closure of a temporary ileostomy)
was published at initiation of the study.15
Participants
After the index operation and before inclusion, consenting
patients were clinically assessed by a surgeon on day 1 to 4 after
index surgery to ensure that there were no clinical signs of
postoperative complications such as infections or clinical signs of
leakage. Patients without any adverse signs were invited to partici-
pate and after informed consent went through further investigation
with a contrast computed tomography scan (CT-scan) or a flexible
endoscopy of the rectum or both. This was performed 6 to 8 days
after stoma creation to make sure that no patients with signs of
anastomotic leakage were included. The CT-scan was performed
with water soluble contrast through a catheter placed in the rectum,
the rectoscopy was performed using either a flexible or rigid recto-
scope. Both procedures were done without general anesthesia.
Further details of the procedure for the clinical assessment and
the CT-scan have been described elsewhere.15 The full list of criteria
for inclusion and exclusion of patients is accessible in the research
protocol.15 All eligible participants were registered in a screening-
log at the involved centers, reporting reasons for noninclusion.
Randomization
Consenting patients who fulfilled the inclusion criteria were
randomized either to the intervention group with early closure
(day 8–13 after stoma creation) or to the control group with late
closure (>12 weeks after stoma creation) of the ileostomy. Random-
ization was done in computer-generated blocks of six. The random-
ization was performed in the surgical ward using sequentially
numbered thick, opaque, sealed envelopes. Blinding of the inter-
vention was not possible.
Procedures
The surgical technique for closure was according to the local
standard procedure and left to the discretion of the surgeon.
Clavien-Dindo classification was used to evaluate postoper-
ative complications.12,13 The classification of each registered com-
plication was made at the participating hospitals, and the clinical
report forms (CRFs) included the full definition of the grades in
the Clavien-Dindo system. Classification was summarized at the
individual level by the CCI.14,16
Outcomes
The primary endpoint was the mean number of complications
after the index-operation and up to 12 months. Five CRFs were
collected at baseline, at closure, and at 3, 6, and 12 months. All
complications within 12 months postoperatively were registered. The
stoma related complications were registered retrospectively by inspec-
tion of patient charts filled in by stoma care therapists during hospital
stay and in the outpatient clinics. Creatinine levels were measured
before index surgery and at closure of the ileostomy. Other variables
recorded prospectively in the CRFs were blood loss, American Society
of Anesthesiologist’s classification (ASA), duration of surgery, height
of tumor localization, level of anastomosis, adjuvant oncological
treatment, length of hospital stay, and complications, endoscopic or
radiologic assessment of the anastomosis, reoperation, or readmission.
The operating surgeon was also given an open-ended question in the
operative-CRF to comment on surgical details.
The coding of the complications was done by research nurses, Copyright © 2016 Wolters Klu
by the surgeon discharging the patient, or by the surgeon operating
 2016 Wolters Kluwer Health, Inc. All rights reserved.the patient. The codings were afterwards examined by one of the
authors (J.P.) not involved in the operation, in order to ensure that no
complications were coded twice, and that the coding was correct for
each complication.
All eligible participants were registered in a screening-log in
the involved centers, reporting reasons for noninclusion. All data
were sent to the trial secretariat and entered into the trial database.
Sample Size
The study protocol specified 72 evaluable patients per group to
have 80% power to detect a 66% reduction in the risk of compli-
cations.15 Because of slow enrollment, fewer evaluable patients were
reached and before data analysis a re-calculation was performed.
With 60 evaluable patients per group we would have 80% power to
detect a 62.5% reduction in the annual mean number of compli-
cations using a 2-sided test with 5% significance level and assuming
a mean complication rate of 0.45 in the control group.
Statistical Methods
A detailed statistical analysis plan was made before data
analysis. Analyses were made on all randomized patients using an
intention to treat perspective (ITT). All primary and secondary
endpoints were analyzed with a generalized linear model with a
log-link function with group (early vs late reversal) and hospital as
factors.17 For the primary endpoint a negative binomial distribution
was used. Results were to be presented as geometric mean ratio, 95%
confidence intervals (CI) and a P-value for the test of a null
hypothesis of no difference in average number of complications
up to 12 months post index-surgery. For the first secondary endpoint
a binomial distribution was used with robust variance estimation
using Generalized Estimating Equations. Results are presented as
risk ratio and 95% CI. For the second secondary endpoint a negative
binomial distribution was used. The familywise error rate was
controlled in the strong sense by a fixed sequence Bonferroni
procedure where the two secondary hypotheses were only tested
at 2.5% level if the primary hypothesis was rejected at the 5% level.18
Sensitivity adjusted analyses were performed with sex, age, body
mass index (BMI), comorbidity, and radiotherapy as covariates.
Ethics and Informed Consent
The project was approved by the Science Ethical Committee
for the Capital Region in Denmark (Protocol ID: H-1–2010–113)
and in Sweden the project was approved by the Ethical Approval
Committee in Go¨teborg (Dnr 064–2011). Before inclusion patients
were informed about the study and all participating patients returned
a signed consent form.
Approval of Data Security
The project was approved by the Data Protection Agency in
Denmark, and by the Personal Data Representative at the Sahlgren-
ska University Hospital, Go¨teborg, Sweden.
Trial Registration
The project was registered at www.clinicaltrials.gov (identi-
fier: NCT01287637) before patient inclusion.
RESULTS
Overall Results
We assessed 418 patients for eligibility, and 291 of these did
not meet the inclusion criteria because of suspected anastomotic
leakage (n ¼ 37), unwillingness to participate (n ¼ 53), other medical
reasons (n ¼ 159), and where inclusion was missed (n ¼ 42) (Fig. 1).wer Health, Inc. All rights reserved.
Hence, 127 patients were randomized and out of these another
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Assessed for eligibility (n=418)  
Did not meet inclusion criteria (n= 291)
- Suspected anastomotic leakage (n=37)
- Unwilling to participate (n=53)
- Excluded due to other medical reasons* (n=159)
- Missed due to other reasons (n=42)Randomized 
(n=127)
Excluded (n=15)
- Centers failed to maintain screening log** (n=8)
- Withdrawn consent (n=3)
- Unclear reason (n=4)
Allocated to early 
closure of loop 
ileostomy (n=55)
Allocated to
late closure of loop 
ileostomy (n=57)
Allocation of patients
Center 1 (n=14)
Center 2 (n=4)
Center 3 (n=5)
Center 4 (n=9)
Center 5 (n=23)
Allocation of patients
Center 1 (n=15)
Center 2 (n=5)
Center 3 (n=5)
Center 4 (n=11)
Center 5 (n=21)
Follow up of patients†
(n=55)
Patients analyzed
(n=55) Patients analyzed 
(n=57)
Follow up of patients††
(n=57)
Deceased due to rectal 
cancer disease‡‡
(n=1)
Deceased due to rectal 
cancer disease‡
(n=1)
* excluded after clinical evaluation (n=91), diabetes (n=28), received permanent stoma or no stoma (n=29), 
steroid treatment (n=3), other (n=8).
** center 6 (n=2), center 7 (n=3) and center 8 (n= 3)
† missing follow up at 3 months: (n=1), at 12 months (n=2)
†† missing follow up at closure: (n=1), 3 months: (n=2), 6 months: (n=3), 12 months: (n=2)
‡ missing follow up at 12 months
‡‡ patient did not go through closure, missing follow up at 12 months FIGURE 1. Participant flow diagram.
Danielsen et al Annals of Surgery  Volume 265, Number 2, February 201715 patients were excluded. In summary, 112 patients were included
from February 2011 and with last follow-up of the last patient in
November 2015. There were 55 patients in the early- and 57 patients
in the late closure group available for analysis, respectively (Fig. 1).
There were no violations of the randomization.
Baseline demographic data are shown in Table 1. The inter- Copyright © 2016 Wolters Kluw
vention group included a larger proportion of females compared with
286 | www.annalsofsurgery.comthe control group (Table 1). In all other respects the groups were
comparable. Perioperative details of loop ileostomy closure and its
postoperative complications were comparable between groups
(Tables 2 and 3).
Median time from index surgery to closure was 11 days in
the early group and 148 days in the late group (Table 2). At 3, 6, ander Health, Inc. All rights reserved.
12-months follow up after index surgery there were more
 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. Baseline and Preoperative Characteristics of Included Patients
Randomization Group
Early Closure Late Closure
Patients (n) 55 57
Age (yrs) 67 (36–82) 67 (39–81)
Sex (female/male) 31 (56%) / 24 (44%) 21 (37%) / 36 (63%
BMI (kg/m2) 24 (17–32) 23 (19–35)
Comorbidity (number of patients) 23 (42%) 24 (42%)
Ischaemic heart disease 5 8
Hypertension 17 13
COPD 2 2
Renal disease 0 0
Other 9y 4z
Radiotherapy 16 (29%) 16 (28%)
If yes, longterm radiotherapy 5 (9%) 5 (9%)
Smoking 6 (11%) 4 (7%)
If yes, number of pack years (years) 30 (16–30)§ 26 (20–50)
Alcohol use (>60 gram of alcohol a day) 0 0jj
Lower border of tumour (cm from anal verge)
5–9 27 (49%) 24 (42%)
10–15 27 (49%) 33 (58%)
>15 1 (2%) 0
Clinical stage according to UICC 54/55 53/57yy
I 12 (22%) 19 (33%)
II 21 (38%) 13 (23%)
III 18 (33%) 20 (35%)
IV 3 (5%) 1 (2%)
Method of evaluation of anastomosis
CT-scan 14 (25%) 19 (33%)
Rectoscopy 14 (25%) 10 (18%)
CT-scan and rectoscopy 27 (49%) 28 (49%)
Total length of hospital stay for index surgery and loop ileostomy closure (days) 14 (11–42) 14 (7–44)
Numbers are in median. Percentages or range is given in parenthesis.
missing data in 2 patients.
yasthma (n¼ 2), depression (n ¼ 1), idiopathic thrombocytopenic purpura (ITP) (n ¼ 1), lymphoma (n ¼ 1), Waldenstro¨m macroglobulinemia (n ¼ 1), osteoporosis (n ¼ 1), Sjo¨gren
syndrome (n ¼ 1), thyrotoxicosis (n ¼ 1).
zdepression (n ¼ 1), hyperlipidaemia (n ¼ 1), hypothyreosis (n ¼ 1), meningioblastoma (n ¼ 1).
§missing data in 3 patients.
missing data in 1 patient.
jjmissing data in 1 patient.
missing data for 1 patient in intervention and control group respectively.
yy3 patients had T0N0M0 and are therefore not classified.
BMI indicates body mass index; COPD, Chronic obstructive pulmonary disease; UICC, Union Internationale Contre le Cancer.
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control group underwent earlier closure because of high-volume
stomal output and stomal retraction, respectively. These events were
regarded as complications classified as Clavien-Dindo Grade IIIb
(Table 3). One patient in the intervention group suffered from severe
renal failure because of high volume output at the 3 months follow up
(classified Clavien-Dindo Grade IVa). This patient had undergone a
failed attempt to closure within 13 days of index surgery, which lead
to prolonged duration of the loop ileostomy. The attempted surgery
was considered a postoperative complication, and the patient
remained in the early closure group on an intention to treat basis.
Primary endpoint: The mean number of complications after
index surgery up to the 12 months follow up was significantly lower in
the intervention group (mean number of complications was 1.24 in the
intervention group compared with 2.88 in the control group) with a
ratio for intervention versus control of 0.42 (95% CI 0.32–0.57), P <
0.0001 (Tables 2 and 3). The adjusted analysis showed similar results.
Secondary Endpoints
When comparing more severe complications (Clavien-Dindo
Grade IIIa or higher), there was no significant difference between the Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
two groups (proportion of patients with at least one complication feasibility of early closure of a temporary ileostomy in selected
 2016 Wolters Kluwer Health, Inc. All rights reserved. www.annalsofsurgery.com | 287)Clavien-Dindo Grade IIIa or higher was 0.22 for the intervention
group and 0.29 for the control group, P ¼ 0.32). The results were
similar in the adjusted analysis.
The mean number of stoma related complications was sig-
nificantly higher in the control group (intervention group 0.30 and
control group 1.25) with a ratio for intervention versus control of 0.25
(95% CI 0.15–0.42), P < 0.0001 (Table 4). The adjusted analysis
showed similar results.
Supporting Endpoints
There was a difference of 15.7 units in median level of CCI
(8.7 and 24.4 for early and late group, respectively).
Creatinine Levels
The mean levels at baseline were 72.7 and 75.8 micromol/L
with average intraindividual changes to closure of 0.40 and 9.20 for
early and late group, respectively.
DISCUSSION
This clinical trial provides evidence of the safety, efficacy, and
TABLE 2. Details of Loop Ileostomy Closure
Randomization Group
Early Closure (n ¼ 55) Late Closure (n ¼ 57)
Time with ileostomy (days) 11 (8–152)y 148 (64–665)z
Bleeding (mL) 5 (0–200) 5 (0–700)
Time duration of surgery (min) 50 (17–180) 71 (31–401)
Anastomosis (ileo-ileal anastomosis)
Handsewn 45 (82%) 40 (70%)
Stapled 10 (18%) 15 (26%)
Epidural anaesthesia 1 (2%) 1 (2%)
Time until passing of gas (days) 1 (0–6) 2 (0–8)
Time until fully oral nutrition (days) 1 (0–23) 2 (0–20)
Time in intensive care unit (days) 0 (0–0) 0 (0–0)
Hospital stay after closure (days) 4 (2–27) 4 (2–28)
Postoperative complication (number of patients) 4 (7%) 4 (7%)§
Classification according to Clavien-Dindo12,13 (number of complications)
Grade I 1 0
Grade II 3 1
Grade IIIa 0 3
Grade IIIb 2 1
Grade IVa 0 0
Grade IVb 0 0
Grade V 0 0
Type of complication
Infection 2 0
Fistula/anastomotic leakage 0 1
Bleeding 0 0
Nausea/vomiting 1 2
Cardiopulmonary 0 0
Liver insufficiency 0 0
Pain 1 1
Allergy 0 0
Pancreatitis 0 0
Other (specification) 2 1jj
Cause of reoperation – after loop ileostomy closure
Failed attempt of stoma closure 1
Small bowel obstruction 1 1
Numbers are in median. Percentages or range is given in parenthesis.
1 patient did not go through closure due to metastatic disease.
y1 patient underwent a failed attempt to closure within 13 days after index surgery, which lead to prolonged duration of the loop ileostomy.
z2 patients underwent closure more than 365 days after index surgery (440 and 665 days, both in the control group). Data were registered retrospectively that enabled identifying
information regarding closure later than the follow-up period. Data on stoma related complications were only registered within the follow-up period of 12 months.
§missing data in 1 patient.
small bowel obstruction (n ¼ 1), failed attempt of stoma closure because of swelling of small bowel (n ¼ 1).
jjsmall bowel obstruction.
Danielsen et al Annals of Surgery  Volume 265, Number 2, February 2017patients with rectal cancer with a follow up of 12 months after index
operation. Only patients assessed for clinically relevant compli-
cations related to the index surgery and who were found appropri-
ately fit were invited to enter the trial. Therefore, only patients not
showing clinical or radiological signs of adverse events after the
rectal cancer operation were included and randomized.
We found a significant difference between the two groups
regarding our primary endpoint, which was the mean number of
complications within 12 months of index surgery. Further, patients in
the intervention group had fewer complications than patients in the
control group during the follow up. There was no significant differ-
ence in the rate of severe complications, grade IIIa, and above
according to the Clavien-Dindo classification. The pattern of severe
complications >CD IIIa varied between intervention and control
groups during the follow-up period (Table 3) and in particular there
seemed to be more severe complications in the control group between
6 and 12 months compared with the intervention group. The total
number of complications differed significantly over time between
9 Copyright © 2016 Wolters Kluw
groups. In the study by Alves et al, patients had an overall morbidity
288 | www.annalsofsurgery.comof 31% in the early closure group and 38% in the late closure group at
90 days after stoma creation, which was similar to our results.
However, they did not report overall complications later in the
follow-up period.
Patients included in this trial were comparable with regard
to baseline characteristics apart from more female participants in
the intervention group. The adjusted analysis showed similar results
with no impact of sex, age, BMI, comorbidity, or neoadjuvant
radiotherapy.
Data on surgical closure of the loop ileostomy did not differ
between the groups, although 3 patients in the intervention group and
4 patients in the control group experienced complications and some
of them had more than one complication. Our results indicated that
early closure of a temporary ileostomy is safe, as has been suggested
before.6 The rate of overall complications reported from other studies
was higher9,19,20 and one possible explanation could be criteria for
inclusion and exclusion in our trial.
We found a significant difference in the mean number ofer Health, Inc. All rights reserved.
stoma related complications, in particular relieving patients in the
 2016 Wolters Kluwer Health, Inc. All rights reserved.
 Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 3. Details of Complications Registered at Follow-up 3, 6, and 12 Months After Index Operation and Including Compli-
cations Occurring From Leaving Hospital Until 3 Months, From 3 to 6 Months and From 6 to 12 Months, Respectively
Classification According to Clavien-Dindo 12,13 (Number of Complications)
Randomization Group
Early Closure (n ¼ 55) Late Closure (n ¼ 57)
3 months missing n ¼ 1 missing n ¼ 2
Postoperative complication (number of patients) 18/55 (33%) 26/57 (46%)
Grade I 7 11
Grade II 4 11
Grade IIIa 5 9
Grade IIIb 4 2
Grade IVa 1 0
Grade IVb 0 0
Grade V 0 0
6 months missing n ¼ 3
Postoperative complication (number of patients) 4/55 (7%) 18/57 (32%)
Grade I 2 14
Grade II 3 7
Grade IIIa 0 3
Grade IIIb 0 0
Grade IVa 0 0
Grade IVb 0 0
Grade V 0 0
12 months missing n ¼ 2 missing n ¼ 2
Postoperative complication (number of patients) 8/55 (15%) 19/57 (33%)
Grade I 5 6
Grade II 2 6
Grade IIIa 1 4
Grade IIIb 1 2
Grade IVa 0 2
Grade IVb 0 0
Grade V 0 0
Reoperations within 12 months - causes 5/55 (9%) 4/57 (7%)
Small bowel obstruction 1 1
Presacral abscess (leakage of the colo-anal anastomosis) 1 2
Abscess 2 0
Bleeding peptic ulcer 1 0
Stenosis in colo-anal anastomosis 0 1
TABLE 4. Details of Complications Related to the Loop Ileostomy From Index Surgery Until Closure of the Stoma
Classification According to Clavien-Dindo12,13 (Number of Complications)
Randomization Group
Early Closure (n ¼ 55) Late Closure (n ¼ 57)
Stoma related complications
Number of patients 13/55 (24%) 44/57 (77%)
Grade I 13 63
Grade II 3 3
Grade IIIa 0 2
Grade IIIb 0 3y
Grade IVa 1 0
Grade IVb 0 0
Grade V 0 0
Type of stoma related complications
Skin irritation 3 16
Stomal ulcer 2 18
Parastomal infection 1 0
Leakage outside appliance bag 3 17
High volume output 5 9
Parastomal hernia 0 2
Stenosis 2 2
Prolaps 0 1
Retraction 0 2
Other 1 4
Renal failure becuase of high volume output. This patient underwent a failed attempt to closure within 13 days after index surgery, which lead to delayed loop ileostomy closure.
y(i) Stomal retraction (n ¼ 1), which lead to earlier closure, (ii) symptomatic parastomal hernia (n ¼ 1), which was sutured at closure, and (iii) high volume output (n ¼ 1), which
lead to earlier closure of the loop ileostomy.
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with leakage and of high-volume output. Although stoma related
complications may seem less severe than complications > IIIa in the
Clavien-Dindo classification, these complications can be tiresome,
distressing, and embarrassing for the patient.21,22 The observed
difference in median CCI of 15.7 units pointed to a clinically relevant
advantage for the intervention group.14
Many patients have their loop ileostomy considerably longer
than the suggested 12 weeks, which also could be seen in our study
where median time until closure in the control group was 148 days
(equivalent to 5 months). Other studies have pointed out that 20% of the
temporary ileostomies were never closed,23 but only 3 patients (3%) in
our trial did not undergo closure within the follow-up period of
12 months after index surgery. Of those, two patients did eventually
undergo reversal of the loop ileostomy, although later than 12 months
after index surgery, and the third patient who deceased from metastatic
disease within 12 months was regarded as a permanent loop ileostomy
carrier. Previous reports have suggested reasons for nonclosure as old
age, surgical complications, and comorbidity.5 Possible explanations
for the high closure rate <12 months in our trial most likely include
focus on closure of the ileostomy in the trial setting.
In accordance with the report by Gessler et al,4 we found that a
temporary ileostomy has a negative effect on renal function, reflect-
ing that for a few individuals a loop ileostomy may have a systemic
effect as well.
Strengths of this trial include the randomized design, the
screening log at the including hospitals enabling an evaluation of
external validity and the thorough examination of patients after
inclusion and before randomization to ascertain that patients did
not have a subclinical anastomotic leakage.
It could be considered a limitation that not all patients
screened for participation were included because of the strict
inclusion criteria. We screened 418 patients in the participating
centers and only 127 patients were included and randomized and
finally 112 patients were included in the analysis (Fig. 1). However,
this was a safety measure and even if only 30% of the entire group
can undergo early closure this represents significant improvements
for the patients. The screening-logs were complete and all non-
included patients were registered with specific reasons for the non-
inclusion. Another limitation was the coding of complications as it
was not possible to blind the surgeon or the research nurse who
carried out the actual coding of the complications, which may have
led to observer bias.
CONCLUSIONS
We found that in selected patients without clinical, radiologi-
cal, or endoscopic signs of a leakage early closure of the temporary
ileostomy after surgery for rectal cancer resulted in a significantly
lower mean number of complications compared with late closure. We
also found low numbers of severe complications in both groups
suggesting that patients should be considered for early closure of an
ileostomy if they have no signs of anastomotic leakage in the
postoperative period after rectal resection.
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